Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04439396 · ClinicalTrials.gov registry record · Phase 1

Toradol (Ketorolac) in Breast Surgery to Reduce Pain & Opioid Use

A Phase 1 study of Breast Reconstruction and Breast Reduction, sponsored by Carilion Clinic.

Completed
Registry status
Phase 1
Development phase
183
Enrollment target
1
Study location

NCT04439396 is a Phase 1 study of Breast Reconstruction and Breast Reduction that has completed, run by Carilion Clinic. The registered enrollment target is 183 participants, below the 384-participant average among 18 other Breast Reconstruction trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04439396, a Phase 1 study of Breast Reconstruction and Breast Reduction, has completed, sponsored by Carilion Clinic.

COMPLETED
Registry status
Phase 1
Development phase
183 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate whether perioperative single-dose administration of ketorolac (Toradol) can reduce post-operative pain after breast surgery, thereby decreasing post-operative opioid use.

Interventions

  • OTHER Saline
  • DRUG Ketorolac Tromethamine

Study Locations (1)

Virginia

  • James T. Thompson - Roanoke

Trial Details

FieldValue
Enrollment Target 183 participants
Start Date 2020-06-22
Est. Completion 2023-01-30
Phase Phase 1

Sponsor

Carilion Clinic

45 total trials

What the Registry Record Tells You About NCT04439396

The ClinicalTrials.gov registry entry for NCT04439396 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 183 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 384-participant average among 18 other Breast Reconstruction trials with a reported enrollment target (52% lower). The listed sponsor is Carilion Clinic, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Breast Reconstruction appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.

NCT04439396 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT04439396 about?

NCT04439396 is a clinical study titled "Toradol (Ketorolac) in Breast Surgery to Reduce Pain & Opioid Use". The purpose of this study is to investigate whether perioperative single-dose administration of ketorolac (Toradol) can reduce post-operative pain after breast surgery, thereby decreasing post-operative opioid use.

What is the current status of trial NCT04439396?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 183 participants. The study started on 2020-06-22. Estimated completion is 2023-01-30.

What conditions does trial NCT04439396 study?

This clinical trial studies the following conditions: Breast Reconstruction, Breast Reduction.

What interventions are being tested in trial NCT04439396?

The interventions under investigation include: Saline (OTHER), Ketorolac Tromethamine (DRUG).

Who is sponsoring clinical trial NCT04439396?

This trial is sponsored by Carilion Clinic, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04439396 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Reconstruction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.